Page 5 - Cytokinetics Daily News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cytokinetics daily. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cytokinetics Daily Today - Breaking & Trending Today

Cytokinetics (NASDAQ:CYTK) Price Target Cut to $70.00

Cytokinetics (NASDAQ:CYTK – Free Report) had its price objective decreased by Raymond James from $92.00 to $70.00 in a research note released on Thursday, Benzinga reports. Raymond James currently has an outperform rating on the biopharmaceutical company’s stock. Other analysts have also recently issued reports about the company. Truist Financial reissued a buy rating and […] ....

Fady Ibraham Malik , Raymond James , Johnt Henderson , Victory Capital Management Inc , Vanguard Group Inc , Cytokinetics Company Profile , Needham Company , Legato Capital Management , Cytokinetics Incorporated , Free Report , Moderate Buy , Get Free Report , Ibraham Malik , Director John , Minvest Partners , Capital Management , Victory Capital Management , Cytokinetics Daily ,

Needham & Company LLC Trims Cytokinetics (NASDAQ:CYTK) Target Price to $72.00

Cytokinetics (NASDAQ:CYTK – Free Report) had its price objective cut by Needham & Company LLC from $108.00 to $72.00 in a report released on Thursday morning, Benzinga reports. They currently have a buy rating on the biopharmaceutical company’s stock. Other analysts also recently issued reports about the company. JMP Securities reduced their price objective on […] ....

United States , Johnt Henderson , Fady Ibraham Malik , Victory Capital Management Inc , Cytokinetics Incorporated , Needham Company , Securities Exchange Commission , California Public Employees Retirement System , Jump Financial , Cytokinetics Company Profile , Free Report , Moderate Buy , Trading Down , Get Free Report , Ibraham Malik , Exchange Commission , Director John , Retirement System , Public Employees Retirement System , Capital Management , State Retirement System , Cytokinetics Daily ,

Cytokinetics (NASDAQ:CYTK) Given New $72.00 Price Target at Needham & Company LLC

Cytokinetics (NASDAQ:CYTK – Free Report) had its price target reduced by Needham & Company LLC from $108.00 to $72.00 in a research report report published on Thursday morning, Benzinga reports. They currently have a buy rating on the biopharmaceutical company’s stock. A number of other analysts have also recently issued reports on CYTK. Mizuho reduced […] ....

Fady Ibraham Malik , Johnt Henderson , Cytokinetics Incorporated , Legato Capital Management , Needham Company , Vanguard Group Inc , Victory Capital Management Inc , Securities Exchange Commission , Free Report , Moderate Buy , Get Free Report , Director John , Exchange Commission , Ibraham Malik , Minvest Partners , Capital Management , Victory Capital Management , Cytokinetics Daily ,

HC Wainwright Trims Cytokinetics (NASDAQ:CYTK) Target Price to $90.00

Cytokinetics (NASDAQ:CYTK – Free Report) had its price target lowered by HC Wainwright from $94.00 to $90.00 in a report released on Thursday, Benzinga reports. The brokerage currently has a buy rating on the biopharmaceutical company’s stock. CYTK has been the topic of several other research reports. JMP Securities reduced their price target on shares […] ....

Johnt Henderson , Raymond James , Fady Ibraham Malik , Third Bancorp , Fifth Third Bancorp , Bessemer Group Inc , Securities Exchange Commission , Entrypoint Capital , Sage Rhino Capital , Cytokinetics Incorporated , Free Report , Moderate Buy , Get Free Report , Director John , Ibraham Malik , Exchange Commission , Point Capital , Cytokinetics Daily ,

Bank of America Cuts Cytokinetics (NASDAQ:CYTK) Price Target to $60.00

Cytokinetics (NASDAQ:CYTK – Free Report) had its price target lowered by Bank of America from $70.00 to $60.00 in a research report report published on Thursday, Benzinga reports. The firm currently has a neutral rating on the biopharmaceutical company’s stock. Other equities research analysts have also issued reports about the company. Barclays decreased their target […] ....

United States , Raymond James , Johnt Henderson , Fady Ibraham Malik , Sage Rhino Capital , Cytokinetics Incorporated , Securities Exchange Commission , Entrypoint Capital , Cytokinetics Company Profile , Bessemer Group Inc , Third Bancorp , Fifth Third Bancorp , Free Report , Moderate Buy , Get Free Report , Ibraham Malik , Director John , Exchange Commission , Point Capital , Cytokinetics Daily ,